Oncological Outcomes of Different Patterns of Tumor Recurrence at First Evaluation After Bacillus Calmette-Guérin Induction Therapy for Intermediate and High Risk Non Muscle Invasive Bladder Cancer

• Status: Completed
• Trial end date: 2020-03-18
• Target enrollment: 0
• Participant gender: All

Summary

This retrospective study aimed at assessment of different patterns (morphological and pathological) of tumor recurrence found at first evaluation after BCG induction therapy (3 months cystoscopy) for intermediate and high-risk NMIBC and its prognostic implications at a tertiary referral center.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mansoura University
• Treatments: BCG Vaccine

Criteria

Inclusion Criteria:

• Patients for who complete TURBT, was carried out

• Intermediate and high risk NMIBC.

• Patients who received full induction BCG regimen (6 weekly doses).

• Patients completed at least 12 months follow up after 3 months cystoscopy.

Exclusion Criteria:

• Patients who received incomplete induction BCG regimen (less than 6 weekly doses)

• Patients with incomplete (less than 12 months) follow up.